Skip to main content
. 2021 Jul 14;11:720125. doi: 10.3389/fonc.2021.720125

Table 1.

Prognosis analysis of immune checkpoints in KIRC.

Genes Overall Survival Progression Free Survival Disease Free Survival
p-value HR (95%CI) p-value HR (95%CI) p-value HR (95%CI)
SIGLEC15 0.928 1.01 (0.75-1.37) 0.375 0.87 (0.63-1.19) 0.862 0.97 (0.66-1.41)
CD274 0.024 0.71 (0.52-0.96) 0.024 0.70 (0.51-0.96) 0.0092 0.60 (0.41-0.89)
HAVCR2 0.0098 0.67 (0.50-0.91) 0.0046 0.63 (0.46-0.87) 0.0046 0.58 (0.39-0.85)
PDCD1 0.199 1.22 (0.90-1.64) 0.092 1.31 (0.96-1.79) 0.087 1.40 (0.95-2.05)
CTLA4 0.019 1.43 (1.06-1.93) 0.0012 1.68 (1.22-2.32) 0.00098 1.84 (1.25-2.72)
LAG3 0.017 1.44 (1.07-1.95) 0.075 1.33 (0.97-1.82) 0.014 1.64 (1.11-2.43)
PDCD1LG2 0.151 0.80 (0.59-1.08) 0.227 0.82 (0.60-1.13) 0.211 0.78 (0.54-1.15)
TIGIT 0.186 1.22 (0.91-1.65) 0.14 1.27 (0.92-1.73) 0.096 1.11 (0.83-1.52)